New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2012
09:01 EDTMYGN, DECK, YHOO, DF, SVU, HMA, DELLOn The Fly: Pre-market Movers
HIGHER: Supervalu (SVU), up 11% after WSJ report on Cerberus' options in potential deal... Deckers Outdoor (DECK), up 9% after Sterne Agee upgrade, Jefferies' positive comments... Dell (DELL), up 5% after upgrade to Buy from Sell at Goldman... Dean Foods (DF), up 5% after sale of Morningstar Foods unit for $1.45B... LOWER: Myriad Genetics (MYGN), down 4% after Supreme Court ruling, downgrades at Goldman and Mizuho... Health Management (HMA), down 3% after negative "60 Minutes" report... Yahoo! (YHOO), down 2% after reporting $2.7B non-final judgment in lawsuit in Mexico...
News For SVU;DECK;DELL;DF;MYGN;HMA;YHOO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 27, 2015
08:06 EDTYHOOFollow-up: Yahoo initiated with an Overweight at Morgan Stanley
Subscribe for More Information
06:43 EDTYHOOJon McCormack returns to Amazon two months after leaving for Yahoo, BI says
Subscribe for More Information
March 26, 2015
19:16 EDTYHOOOn The Fly: After Hours Movers
Subscribe for More Information
17:24 EDTYHOOMorgan Stanley says Yahoo attractive way to buy Alibaba
Subscribe for More Information
17:22 EDTYHOOYahoo approves additional share repurchase program of $2B
Subscribe for More Information
17:19 EDTYHOOYahoo approves additional share repurchase program of $2B
16:33 EDTYHOOYahoo initiated with an Overweight at Morgan Stanley
Subscribe for More Information
13:51 EDTYHOOYahoo updates transparency report
Subscribe for More Information
11:30 EDTYHOOStocks with call strike movement; HAL YHOO
Subscribe for More Information
10:04 EDTMYGNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:41 EDTYHOOTwitter to outpace Yahoo in display ad revenue, WSJ says
Subscribe for More Information
06:07 EDTMYGNMyriad Genetics downgraded to Sell from Neutral at Goldman
Subscribe for More Information
March 25, 2015
06:04 EDTDFClean Energy agrees with Dean Foods to construct natural gas station
Clean Energy (CLNE) announced an agreement with Dean Foods (DF) to construct a compressed natural gas station at its Oak Farms Dairy plant in Houston, Texas. Beginning in the second half of 2015, the station will be used to fuel the CNG vehicles deployed by Dean Foods. Over the next several months, Dean Foods will introduce 57 CNG Freightliner M2-112 straight trucks and 7 Freightliner Cascadia over-the-road tractors powered by the Cummins ISL-G and ISX12-G engines, respectively and outfitted with Agility CNG fuel tanks.
March 23, 2015
08:29 EDTYHOOYahoo's Tumblr to contribute revenues in 2015, says BofA/Merrill
Subscribe for More Information
07:53 EDTYHOOYahoo volatility at low end historic range
Yahoo March weekly call option implied volatility is at 27, April is at 24, May and July is at 27; compared to its 26-week average of 35 according to Track Data, suggesting decreasing price movement.
07:44 EDTYHOOYahoo price target lowered to $61 from $66 at BofA/Merrill
BofA/Merrill lowered Buy rated Yahoo's (YHOO) price target to $61 to reflect a lower valuation for the Alibaba (BABA) stake.
March 20, 2015
07:41 EDTMYGNAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
05:17 EDTMYGNMyriad EMPATHY-P clinical study results to be highlighted at annual congress
Myriad Genetics announced that results from the EMPATHY-P clinical study of Prolaris in patients newly diagnosed with prostate cancer will be highlighted at the 30th Annual Congress of the European Association of Urology. The EMPATHY-P study evaluated the Prolaris test on 525 patient biopsy samples to determine the aggressiveness of prostate cancer in these newly diagnosed patients from five European countries including: Italy, Germany, Spain, Switzerland and the UK. The patients' biopsy samples also were evaluated using standard clinical pathology methods, which were then compared to the Prolaris test results. The EMPATHY-P data showed, overall, that the Prolaris test found 42% of the European men evaluated had a risk profile that was either lower or higher than would be expected using clinical pathology. Interestingly, this finding is consistent with the previously published U.S. Prostate Biopsy Research study, which found 51% of U.S. patients had a risk profile that differed from clinical pathology.
March 18, 2015
17:50 EDTYHOOYahoo exits China operations, WSJ says
Subscribe for More Information
10:06 EDTYHOOYahoo to close Beijing R&D office, SCMP says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use